Company intelligence / Profile preview

PEMFbio

Ownership: Private
Development stage: Commercial

Overview

PEMF therapy devices are FDA-cleared for certain indications such as bone healing and pain management. The technology is non-invasive and has been used in both clinical settings and home care. Evidence supports benefits in cellular repair, circulation improvement, inflammation reduction, and enhanced recovery from injury. However, efficacy varies by indication and more research is ongoing.

Therapeutic areas: EndocrinologyImmunologyOtherDermatologyRheumatologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on PEMFbio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PEMFbio.

Explore the full profile